Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

Real-time Quote. Real-time BATS US - 05/24 04:59:54 pm
37.715 USD   +0.63%
1d ago Valeant near deal to acquire Bausch & Lomb
1d agoDJBausch & Lomb Nears $9 Billion Sale to Valeant
2d agoDJRoyalty Pharma Lowers Acceptance Threshold For Elan Offer
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 

Abbott Laboratories : Abbott Declares 355th Consecutive Quarterly Dividend

09/13/2012| 11:05am US/Eastern
Recommend:
0

ABBOTT PARK, Ill., Sept. 13, 2012 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 51 cents per share.

This marks the 355(th) consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2012, to shareholders of record at the close of business on Oct. 15, 2012.

Abbott has increased its dividend payout for 40 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott

Recommend :
0
Partner Area
React to this article
 
Latest news on ABBOTT LABORATORIES
1d ago Valeant near deal to acquire Bausch & Lomb
1d agoDJBausch & Lomb Nears $9 Billion Sale to Valeant
2d agoDJRoyalty Pharma Lowers Acceptance Threshold For Elan Offer
3d ago ABBOTT LABORATORIES: Abbott to Present at Deutsche Bank 38th Annual Health Care..
4d ago ABBOTT LABORATORIES: Abbott Announces CE Mark for World's Longest Coronary Drug..
5d agoDJRoyalty Pharma Raises Takeover Bid for Elan
05/14DJAbbVie, Alvine Pharma to Collaborate on Investigational Drug for Celiac Disea..
05/10DJAbbVie Chief Scientific Officer John Leonard to Retire
05/09 ABBOTT LABORATORIES: Abbott Announces CE Mark for Test to Aid Doctors with Diag..
05/08 ABBOTT LABORATORIES: Abbott to Present at UBS Global Healthcare Conference
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.